Market Cap

ImmunoGen, Inc. Market Capitalization:

$8.25 Billion

USD as of Jan. 1, 2024

business ImmunoGen, Inc. Company Profile

ImmunoGen, Inc. Main Stock Listing

NASDAQ: IMGN

Market Capitalization History of ImmunoGen, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Yearly evolution of ImmunoGen, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2024 $8.25 B 724.65%
Jan. 1, 2023 $1.00 B -19.82%
Jan. 1, 2022 $1.25 B -20.76%
Jan. 1, 2021 $1.57 B 51.06%
Jan. 1, 2020 $1.04 B -10.10%
Jan. 1, 2019 $1.16 B -42.81%
Jan. 1, 2018 $2.03 B 292.31%
Jan. 1, 2017 $516.6 M -72.44%
Jan. 1, 2016 $1.87 B 11.27%
Jan. 1, 2015 $1.68 B -49.10%
Jan. 1, 2014 $3.31 B 4.68%
Jan. 1, 2013 $3.16 B 1.42%
Jan. 1, 2012 $3.12 B 70.94%
Jan. 1, 2011 $1.82 B 18.17%
Jan. 1, 2010 $1.54 B 67.63%
Jan. 1, 2009 $920.5 M 19.83%
Jan. 1, 2008 $768.2 M -25.64%
Jan. 1, 2007 $1.03 B 16.71%
Jan. 1, 2006 $885.2 M -42.47%
Jan. 1, 2005 $1.54 B 4.65%
Jan. 1, 2004 $1.47 B 122.74%
Jan. 1, 2003 $660.0 M -74.90%
Jan. 1, 2002 $2.63 B -46.02%
Jan. 1, 2001 $4.87 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

🐷

"Bulls make money...
Bears make money...
Pigs get slaughtered!"

Stop guessing, unlock Financial AI.

(Don't be a pig.)

Stocks & Indices

ImmunoGen, Inc. has the following listings and related stock indices.


Stock: NASDAQ: IMGN

Stock: FSX: IMU

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.